Research Topics
| Dale L BarnardSummaryAffiliation: Utah State University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day
Institute for Antiviral Research, Utah State University, UMC 5600, Logan, UT 84322 5600, USA
Virology 395:210-22. 2009..Ribavirin, UDA, and Ampligen decreased IL-6 expression. Strain v2163 provided a valuable model for anti-SARS research...
Animal models for the study of influenza pathogenesis and therapyDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, UT 84322 5600, USA
Antiviral Res 82:A110-22. 2009..This review describes models currently in use for elucidating influenza pathogenesis and evaluating new therapeutic agents...
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse modelDale L Barnard
Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, UT 84322 5600, USA
Antiviral Res 79:105-13. 2008..Thus, promazine did not affect SARS-CoV replication in vitro or in vivo, nor were any other phenothiazines efficacious in reducing virus replication. Therefore, treating SARS infections with compounds like promazine is not warranted...
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, 84322 5600, USA
Antiviral Res 71:53-63. 2006..Our data do not support the use of ribavirin or other IMP dehydrogenase inhibitors for treating SARS infections in humans...
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c miceDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, UT, USA
Antivir Chem Chemother 17:275-84. 2006..In summary, the data suggest that induction of IFN by mismatched dsRNA or actual treatment with exogenous IFN-alpha can inhibit SARS-CoV replication in the lungs of mice...
Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c miceYohichi Kumaki
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
Antivir Chem Chemother 20:169-77. 2010..We previously reported that interferon (IFN) alfacon-1 was more active against SARS-CoV infection in human bronchial epithelial Calu-3 cells than in African green monkey kidney epithelial cells on day 3 post-infection...
Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutininYohichi Kumaki
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, 5600 Old Main Hill, Utah State University, Logan, UT 84322, USA
Antiviral Res 90:22-32. 2011..These data support the conclusion that UDA might bind to N-acetylglucosamine-like residues present on the glycosylated envelope glycoproteins, thereby preventing virus attachment to cells...
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in miceRobert W Sidwell
Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, UT 84322 5600, USA
Antimicrob Agents Chemother 51:845-51. 2007..These data indicate that T-705 may be useful for the treatment of avian influenza virus infections...
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in miceDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, UT, USA
Antivir Chem Chemother 18:125-32. 2007..The data suggest that the prophylactic use of ZnAL42 is effective against avian influenza H5N1 or H1N1 virus infection in mice and should be further explored as an option for treating human influenza virus infections...
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse modelYohichi Kumaki
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, 5600 Old Main Hill, Logan, Utah State University, Logan, UT 84322, USA
Antiviral Res 89:75-82. 2011..001). The data suggest that mDEF201 is a new class of antiviral agent further development as treatment for SARS-CoV infections...
In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infectionsYohichi Kumaki
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, 5600 Old Main Hill, Logan, Utah State University, Logan, UT 84322, USA
Antiviral Res 92:329-40. 2011..05). Given the demonstrated in vitro and in vivo inhibition of avian influenza virus replication, 2'FdC may qualify as a lead compound for the development of agents treating influenza virus infections...
Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cellsYohichi Kumaki
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Science, Utah State University, 5600 Old Main Hill, Logan, UT 84322 5600, USA
Biochem Biophys Res Commun 371:110-3. 2008..The data might provide an important insight into the mechanism of pathogenesis of SARS-CoV allowing further development of antiviral therapies for treating SARS infections...
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidineDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, UT, USA
Antivir Chem Chemother 15:15-22. 2004..These compounds or analogues warrant further evaluation as potential therapies for treating SARS or could be used as lead compounds for discovery of more potent SARSCoV inhibitors...
Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP)Jason P Roth
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, USA
Curr Protoc Microbiol . 2010..Ultimately, cells infected with the rHPIV3-EGFP virus will emit green fluorescence that can be photographed and quantitated...
Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virusJustin G Julander
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, 4700 Old Main Hill, Logan, UT 84322 5600, United States
Antiviral Res 92:228-36. 2011..Moreover, a combination of these two drugs further improved these parameters. Plethysmography provides a sensitive evaluation of lung function in IAV-infected mice in response to antiviral therapy...
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT 84322 5600, USA
Antiviral Res 82:12-21. 2009..Thus, the use of an EGFP-based antiviral assay for testing potential antiviral compounds against HPIV-3 in a high-throughput format may be justified...
Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virusDonald F Smee
Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, Utah, USA
Antivir Chem Chemother 19:15-24. 2008..The antipoxviral activities and phosphorylation of N-methanocarbathymidine ([N]-MCT) and four 5-halo-2'-deoxyuridines, namely 5-fluoro-(FdU), 5-chloro-(CldU), 5-bromo-(BrdU), and 5-iodo-(IdU) derivatives, were explored...
Interferon alfacon-1 protects hamsters from lethal pichinde virus infectionBrian B Gowen
Institute for Antiviral Research, 5600 Old Main Hill, Utah State University, Logan, UT 84322, USA
Antimicrob Agents Chemother 49:2378-86. 2005..These data are the first report demonstrating efficacious treatment of acute arenaviral disease with alpha interferon therapy, and further study is warranted...
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compoundsDonald F Smee
Department of Animal, Dairy and Veterinary Sciences, Institute for Antiviral Research, Utah State University, Logan, UT 84322 5600, USA
J Virol Methods 106:71-9. 2002..These methods should also be applicable to evaluating antiviral effects against other lytic virus infections...
Interferon-alpha. Amarillo BiosciencesDale L Barnard
Utah State University, Institute for Antiviral Research, Logan 84322 5600, USA
Curr Opin Investig Drugs 3:693-7. 2002..The product is registered in Ghana for the treatment of HBV infection. In October 2001, Amarillo licensed rights to its low-dose oral IFNalpha to Atrix Laboratories for the Orphan indications of oral papillomavirus and Behçet's disease...
American Society for Virology-23rd annual meeting. Vaccines and antiviral agents 10-14 July 2004, Montreal CanadaDale L Barnard
Utah State University, Institute of Antiviral Research, Department ADVS, 5600 Old Main Hill, Logan, UT 84322-5600, USA
IDrugs 7:822-4. 2004
Inhibitors of measles virusDale L Barnard
Institute for Antiviral Research, Dept ADVS, Utah State University, Logan, UT, USA
Antivir Chem Chemother 15:111-9. 2004..Thus, further research is needed to develop more potent and less toxic drugs that could be used for treating MV infections to supplement the existing MV vaccine campaigns...
Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replicationDale L Barnard
Institute for Antiviral Research, Utah State University, Logan, USA
Antivir Chem Chemother 13:39-59. 2002..This and related compounds may be valuable leads in the development of a potent and selective class of MV inhibitors that could be used in future in the clinic...
Respiratory syncytial virus infections: recent prospects for controlRobert W Sidwell
Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, UT 84322 5600, United States
Antiviral Res 71:379-90. 2006..In this review, updates on the status of the approved anti-RSV antibodies, ribavirin, and recent results of studies with potential new anti-RSV compounds are summarized and discussed...
Current status of anti-picornavirus therapiesDale L Barnard
Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, Utah, 84322 5600, USA
Curr Pharm Des 12:1379-90. 2006..Thus, these results strongly emphasize the need for the development of potent and nontoxic compounds for the treatment of picornavirus infections...
Novel 3-sulphonamido-quinazolin-4(3H)-one derivatives: microwave-assisted synthesis and evaluation of antiviral activities against respiratory and biodefense virusesPeriyasamy Selvam
Arulmigu Kalasalingam College of Pharmacy, Krishnankoil 626190, India
Antivir Chem Chemother 18:301-5. 2007..Compound 5 was also moderately active against VEE and Tacaribe viruses. The methodology described in this report is applicable for rapid synthesis of many compounds with potential antiviral properties...
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirusKeith G Watson
Biota Chemistry Laboratory, School of Chemistry, Monash University, PO Box 23 Victoria, Australia 3800
J Med Chem 46:3181-4. 2003..Compound 14 illustrates that an oxime ether group can act as a metabolically stable bioisostere for an ester functionality...
in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring systemNing Zhang
Laboratory for Drug Design and Synthesis, Department of Chemistry and Biochemistry, University of Maryland, Baltimore County 21250, USA
Bioorg Med Chem Lett 12:3391-4. 2002..Both compounds showed higher anti-MV activity than the control drug ribavirin...
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceMary C Hu
GlaxoSmithKline Biologicals North America of Washington, 19204 North Creek Parkway, Bothell, WA 98011, USA
Vaccine 25:6334-40. 2007..Following live virus challenge of aged mice, no virus was detected in the lungs of intranasally immunized mice, in contrast to intramuscularly immunized mice whose lung virus titers were comparable to those observed in control mice...
Neutralizing viruses in suspensions by copper oxide-based filtersGadi Borkow
Ruth Ben Ari Institute of Clinical Immunology, Kaplan Medical Center, Rehovot 76100, Israel
Antimicrob Agents Chemother 51:2605-7. 2007..Enveloped, nonenveloped, RNA, and DNA viruses were affected, suggesting the possibility of using copper oxide-containing devices to deactivate a wide spectrum of infectious viruses found in filterable suspensions...
Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV)Chung K Chu
The University of Georgia, College of Pharmacy, Athens, GA, USA
Antivir Chem Chemother 17:285-9. 2006..Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity...
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virusG Mani Subramanian
Human Genome Sciences, Inc, Rockville, MD 20850, USA
Chemotherapy 54:176-80. 2008..The type 1 interferons (INF-alpha and INF-beta) are potent antiviral agents. Albumin-INF-alpha and albumin-INF-beta are novel recombinant proteins consisting of IFN-alpha or IFN-beta genetically fused to human albumin...
